Related Experiment Video
Updated: Oct 15, 2025

In vitro Assessment of Aortic Regurgitation Using Four-Dimensional Flow Magnetic Resonance Imaging
Published on: February 25, 2022
Evaluation of Pulmonary Hypertension Using 4D Flow MRI
John W Cerne1, Ashitha Pathrose1, Daniel Z Gordon2
1Department of Radiology, Northwestern University, Chicago, Illinois, USA.
Four-dimensional (4D) flow MRI can identify pulmonary arterial hypertension (PAH) by detecting lower pulmonary artery velocities. This technique may also help track changes in pulmonary vascular resistance (PVR) in patients with PH.
Area of Science:
- Cardiovascular Imaging
- Medical Physics
- Pulmonary Medicine
Background:
- Cardiac magnetic resonance imaging (MRI) is emerging as a non-invasive alternative to right heart catheterization (RHC) for pulmonary hypertension (PH) evaluation.
- Further research is needed to establish cardiac MRI's capability in characterizing PH.
Purpose of the Study:
- To assess the utility of four-dimensional (4D) flow MRI-derived pulmonary artery velocities for characterizing PH.
- To evaluate the correlation between these velocities and established PH metrics.
Main Methods:
- A prospective case-control study involving 54 PH patients and 25 controls.
- Utilized 1.5T 4D flow and cine MRI sequences to measure pulmonary artery velocities and cardiac volumes.
- Pulmonary vascular resistance (PVR) was derived from RHC, serving as a reference standard.
Main Results:
- Significantly lower peak and mean pulmonary artery velocities were observed in PAH patients compared to controls at the left and right pulmonary arteries.
- Pulmonary artery velocities showed significant correlations with right ventricular ejection fraction and end-systolic volume index.
- Moderate correlations were found between peak velocities and PVR in specific PH subgroups (PAH, PH-LHD, PH-CLD).
Conclusions:
- Four-dimensional (4D) flow MRI demonstrates potential for identifying pulmonary arterial hypertension (PAH).
- The technique shows promise in non-invasively tracking pulmonary vascular resistance (PVR) changes in PH patients.
- Further validation is warranted, particularly for chronic thrombo-embolic PH (CTE-PH).
More Related Videos
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
09:57Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training
Published on: January 18, 2021